133 related articles for article (PubMed ID: 16538643)
1. Detection of carcinomas in an asymptomatic Chinese population: advantage of screening with multiple tumor markers.
Tsao KC; Wu TL; Chang PY; Hong JH; Wu JT
J Clin Lab Anal; 2006; 20(2):42-6. PubMed ID: 16538643
[TBL] [Abstract][Full Text] [Related]
2. Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Tsao KC; Hong JH; Wu TL; Chang PY; Sun CF; Wu JT
J Clin Lab Anal; 2007; 21(3):193-6. PubMed ID: 17506483
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers in the diagnosis of malignant serous effusions.
Cascinu S; Del Ferro E; Barbanti I; Ligi M; Fedeli A; Catalano G
Am J Clin Oncol; 1997 Jun; 20(3):247-50. PubMed ID: 9167746
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
[TBL] [Abstract][Full Text] [Related]
6. TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Pectasides D; Bafaloucos D; Antoniou F; Gogou L; Economides N; Varthalitis J; Dimitriades M; Kosmidis P; Athanassiou A
Am J Clin Oncol; 1996 Jun; 19(3):271-7. PubMed ID: 8638540
[TBL] [Abstract][Full Text] [Related]
7. Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers.
Wang HY; Hsieh CH; Wen CN; Wen YH; Chen CH; Lu JJ
PLoS One; 2016; 11(6):e0158285. PubMed ID: 27355357
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
[TBL] [Abstract][Full Text] [Related]
10. A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
He M; Wu C; Xu J; Guo H; Yang H; Zhang X; Sun J; Yu D; Zhou L; Peng T; He Y; Gao Y; Yuan J; Deng Q; Dai X; Tan A; Feng Y; Zhang H; Min X; Yang X; Zhu J; Zhai K; Chang J; Qin X; Tan W; Hu Y; Lang M; Tao S; Li Y; Li Y; Feng J; Li D; Kim ST; Zhang S; Zhang H; Zheng SL; Gui L; Wang Y; Wei S; Wang F; Fang W; Liang Y; Zhai Y; Chen W; Miao X; Zhou G; Hu FB; Lin D; Mo Z; Wu T
Gut; 2014 Jan; 63(1):143-51. PubMed ID: 23300138
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
12. [Differences in assay sensitivity of selected tumor markers in head and neck neoplasms].
Adamiak G; Jurkiewicz D; Polberg K; Konieczna M
Otolaryngol Pol; 1995; 49 Suppl 20():99-101. PubMed ID: 9454232
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z; Yuan F; Chen R; Li Y; Ma J; Yan X; Wang L; Zhang F; Tao H; Guo D; Huang Z; Zhang S; Li X; Zhi X; Ge X; Hu Y; Wang J
Front Immunol; 2020; 11():1173. PubMed ID: 32587591
[No Abstract] [Full Text] [Related]
14. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients.
Devine PL; McGuckin MA; Ramm LE; Ward BG; Pee D; Long S
Cancer; 1993 Sep; 72(6):2007-15. PubMed ID: 7689923
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
16. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
17. [Clinical usefulness of circulating tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1131-4. PubMed ID: 15272600
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of gastric juice CA 19-9 and CEA levels in gastric carcinoma patients.
Duraker N; Naci Celik A; Gençler N
Eur J Surg Oncol; 2002 Dec; 28(8):844-9. PubMed ID: 12477476
[TBL] [Abstract][Full Text] [Related]
19. Tumor antigens CA 19.9, CA 125, and CEA in carcinoma of the uterine cervix.
Borras G; Molina R; Xercavins J; Ballesta A; Iglesias J
Gynecol Oncol; 1995 May; 57(2):205-11. PubMed ID: 7729735
[TBL] [Abstract][Full Text] [Related]
20. Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening.
Sekiguchi M; Matsuda T
Sci Rep; 2020 Oct; 10(1):18202. PubMed ID: 33097814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]